Sabre Historical Income Statement

SABR Stock

USD 3.76 0.03 0.80%

Historical analysis of Sabre Corpo income statement accounts such as Other Operating Expenses of 3 B, Operating Income of 37.3 M, EBITDA of 104.2 M or Cost Of Revenue of 2.3 B can show how well Sabre Corpo performed in making a profits. Evaluating Sabre Corpo income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Sabre Corpo's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Sabre Corpo latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sabre Corpo is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabre Corpo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

To learn how to invest in Sabre Stock, please use our How to Invest in Sabre Corpo guide.

About Sabre Income Statement Analysis

Sabre Corpo Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sabre Corpo shareholders. The income statement also shows Sabre investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Sabre Corpo Income Statement Chart

At this time, Sabre Corpo's Depreciation And Amortization is relatively stable compared to the past year. As of 11/25/2024, Other Operating Expenses is likely to grow to about 3 B, while Total Revenue is likely to drop slightly above 2.3 B.

Total Revenue Cost Of Revenue Total Operating Expenses Research Development

Total Revenue

Total revenue comprises all receipts Sabre Corpo generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Cost Of Revenue

Cost of Revenue is found on Sabre Corpo income statement and represents the costs associated with goods and services Sabre Corpo provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Sabre Corpo's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Sabre Corpo current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabre Corpo. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

To learn how to invest in Sabre Stock, please use our How to Invest in Sabre Corpo guide.At this time, Sabre Corpo's Depreciation And Amortization is relatively stable compared to the past year. As of 11/25/2024, Other Operating Expenses is likely to grow to about 3 B, while Total Revenue is likely to drop slightly above 2.3 B.

	2021	2022	2023	2024 (projected)
Interest Expense	257.8M	295.2M	447.9M	247.5M
Depreciation And Amortization	262.2M	184.6M	148.7M	160.0M

Interest Expense Depreciation And Amortization

Sabre Corpo income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Research Development	Minority Interest	Discontinued Operations	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Extraordinary Items	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.25	-0.67	-0.21	-0.76	-0.57	-0.62	-0.45	-0.88	0.39	-0.54	-0.3	-0.45	-0.44	0.0	-0.48	-0.34	0.17	-0.34	-0.53	-0.44	0.07	0.27	0.67	0.01	0.0
Interest Expense	0.25		-0.38	-0.33	-0.18	-0.38	-0.54	-0.55	-0.23	0.11	-0.54	-0.64	-0.55	-0.34	0.08	0.17	-0.69	-0.18	-0.55	0.09	0.4	-0.38	-0.41	-0.12	-0.77	-0.82
Total Revenue	-0.67	-0.38		0.78	0.74	0.78	0.92	0.88	0.66	0.02	0.82	0.39	0.82	0.33	0.44	-0.04	0.72	0.03	0.86	0.0	-0.1	0.54	0.16	0.03	0.44	0.43
Gross Profit	-0.21	-0.33	0.78		0.38	0.63	0.8	0.86	0.11	0.42	0.66	0.15	0.71	0.14	0.7	-0.59	0.67	-0.01	0.92	-0.51	-0.49	0.89	0.22	0.54	0.5	0.51
Other Operating Expenses	-0.76	-0.18	0.74	0.38		0.37	0.52	0.39	0.83	0.05	0.35	-0.03	0.34	0.02	0.16	0.44	0.34	-0.11	0.38	0.32	0.37	-0.01	-0.28	-0.42	0.0	0.07
Operating Income	-0.57	-0.38	0.78	0.63	0.37		0.92	0.9	0.56	-0.43	0.97	0.63	0.94	0.7	0.26	-0.16	0.59	0.24	0.78	0.06	-0.02	0.56	0.01	0.07	0.3	0.31
Ebit	-0.62	-0.54	0.92	0.8	0.52	0.92		0.98	0.55	-0.14	0.95	0.58	0.94	0.56	0.39	-0.23	0.77	0.13	0.92	-0.05	-0.19	0.68	0.17	0.12	0.52	0.52
Ebitda	-0.45	-0.55	0.88	0.86	0.39	0.9	0.98		0.4	-0.06	0.95	0.59	0.96	0.52	0.45	-0.39	0.8	0.19	0.97	-0.19	-0.34	0.79	0.27	0.31	0.6	0.59
Cost Of Revenue	-0.88	-0.23	0.66	0.11	0.83	0.56	0.55	0.4		-0.5	0.53	0.33	0.47	0.39	-0.15	0.64	0.32	0.06	0.28	0.61	0.55	-0.18	-0.3	-0.63	-0.05	0.01
Total Operating Expenses	0.39	0.11	0.02	0.42	0.05	-0.43	-0.14	-0.06	-0.5		-0.36	-0.54	-0.27	-0.67	0.56	-0.48	0.03	-0.27	0.16	-0.61	-0.5	0.34	0.28	0.53	0.2	0.16
Income Before Tax	-0.54	-0.54	0.82	0.66	0.35	0.97	0.95	0.95	0.53	-0.36		0.74	0.98	0.7	0.29	-0.21	0.69	0.28	0.86	0.02	-0.14	0.62	0.19	0.12	0.49	0.47
Total Other Income Expense Net	-0.3	-0.64	0.39	0.15	-0.03	0.63	0.58	0.59	0.33	-0.54	0.74		0.73	0.62	-0.07	-0.09	0.49	0.41	0.5	0.2	-0.16	0.28	0.5	0.01	0.6	0.48
Net Income	-0.45	-0.55	0.82	0.71	0.34	0.94	0.94	0.96	0.47	-0.27	0.98	0.73		0.63	0.32	-0.28	0.71	0.38	0.89	-0.02	-0.19	0.67	0.25	0.22	0.53	0.51
Income Tax Expense	-0.44	-0.34	0.33	0.14	0.02	0.7	0.56	0.52	0.39	-0.67	0.7	0.62	0.63		-0.05	0.06	0.3	0.4	0.31	0.37	0.19	0.19	-0.09	-0.21	0.08	0.09
Selling General Administrative	0.0	0.08	0.44	0.7	0.16	0.26	0.39	0.45	-0.15	0.56	0.29	-0.07	0.32	-0.05		-0.49	0.06	-0.15	0.55	-0.49	-0.34	0.57	0.26	0.48	0.21	0.04
Research Development	-0.48	0.17	-0.04	-0.59	0.44	-0.16	-0.23	-0.39	0.64	-0.48	-0.21	-0.09	-0.28	0.06	-0.49		-0.32	-0.07	-0.49	0.76	0.78	-0.79	-0.39	-0.85	-0.45	-0.44
Minority Interest	-0.34	-0.69	0.72	0.67	0.34	0.59	0.77	0.8	0.32	0.03	0.69	0.49	0.71	0.3	0.06	-0.32		0.1	0.78	-0.2	-0.52	0.66	0.38	0.27	0.76	0.87
Discontinued Operations	0.17	-0.18	0.03	-0.01	-0.11	0.24	0.13	0.19	0.06	-0.27	0.28	0.41	0.38	0.4	-0.15	-0.07	0.1		0.12	0.39	0.18	0.09	0.06	0.12	0.06	0.06
Net Income From Continuing Ops	-0.34	-0.55	0.86	0.92	0.38	0.78	0.92	0.97	0.28	0.16	0.86	0.5	0.89	0.31	0.55	-0.49	0.78	0.12		-0.36	-0.48	0.85	0.4	0.45	0.68	0.65
Non Recurring	-0.53	0.09	0.0	-0.51	0.32	0.06	-0.05	-0.19	0.61	-0.61	0.02	0.2	-0.02	0.37	-0.49	0.76	-0.2	0.39	-0.36		0.84	-0.64	-0.39	-0.85	-0.43	-0.43
Non Operating Income Net Other	-0.44	0.4	-0.1	-0.49	0.37	-0.02	-0.19	-0.34	0.55	-0.5	-0.14	-0.16	-0.19	0.19	-0.34	0.78	-0.52	0.18	-0.48	0.84		-0.71	-0.7	-0.8	-0.78	-0.75
Tax Provision	0.07	-0.38	0.54	0.89	-0.01	0.56	0.68	0.79	-0.18	0.34	0.62	0.28	0.67	0.19	0.57	-0.79	0.66	0.09	0.85	-0.64	-0.71		0.36	0.71	0.61	0.61
Interest Income	0.27	-0.41	0.16	0.22	-0.28	0.01	0.17	0.27	-0.3	0.28	0.19	0.5	0.25	-0.09	0.26	-0.39	0.38	0.06	0.4	-0.39	-0.7	0.36		0.51	0.83	0.61
Extraordinary Items	0.67	-0.12	0.03	0.54	-0.42	0.07	0.12	0.31	-0.63	0.53	0.12	0.01	0.22	-0.21	0.48	-0.85	0.27	0.12	0.45	-0.85	-0.8	0.71	0.51		0.49	0.48
Net Interest Income	0.01	-0.77	0.44	0.5	0.0	0.3	0.52	0.6	-0.05	0.2	0.49	0.6	0.53	0.08	0.21	-0.45	0.76	0.06	0.68	-0.43	-0.78	0.61	0.83	0.49		0.92
Reconciled Depreciation	0.0	-0.82	0.43	0.51	0.07	0.31	0.52	0.59	0.01	0.16	0.47	0.48	0.51	0.09	0.04	-0.44	0.87	0.06	0.65	-0.43	-0.75	0.61	0.61	0.48	0.92

Click cells to compare fundamentals

Sabre Corpo Account Relationship Matchups

Sabre Corpo income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	171.9K	363.7M	262.2M	184.6M	148.7M	160.0M
Interest Expense	156.4M	235.1M	257.8M	295.2M	447.9M	247.5M
Total Revenue	4.0B	1.3B	1.7B	2.5B	2.9B	2.3B
Gross Profit	940.0M	(401.6M)	(55.4M)	400.1M	681.5M	669.6M
Other Operating Expenses	3.6B	2.3B	2.4B	2.8B	2.9B	3.0B
Operating Income	363.4M	(988.0M)	(665.5M)	(123.7M)	47.1M	37.3M
Ebit	770.5M	(1.1B)	(693.4M)	(127.1M)	(39.0M)	(37.0M)
Ebitda	770.7M	(730.3M)	(431.2M)	57.5M	109.7M	104.2M
Cost Of Revenue	3.0B	1.7B	1.7B	2.1B	2.2B	2.3B
Total Operating Expenses	576.6M	586.4M	610.1M	661.2M	634.4M	558.6M
Income Before Tax	199.6M	(1.3B)	(938.4M)	(423.4M)	(493.5M)	(468.8M)
Total Other Income Expense Net	(163.8M)	(316.9M)	(272.9M)	(162.4M)	(540.7M)	(513.6M)
Net Income	158.6M	(1.3B)	(923.8M)	(432.1M)	(527.6M)	(501.2M)
Income Tax Expense	35.3M	(39.9M)	(14.6M)	8.7M	34.7M	26.2M
Selling General Administrative	576.6M	586.4K	610.1M	661.2M	639.0M	433.1M
Research Development	1.5B	1.2B	1.1B	1.1B	1.0B	840.3M
Minority Interest	4.0M	1.2M	(2.2M)	(2.7M)	(215K)	(204.3K)
Discontinued Operations	(1.8M)	2.8M	(2.5M)	(679K)	(611.1K)	(580.5K)
Net Income From Continuing Ops	164.3M	(1.3B)	(923.8M)	(432.1M)	(590.4M)	(560.9M)
Non Operating Income Net Other	(7.4M)	(91.1M)	(15.1M)	132.9M	152.8M	160.4M
Net Income Applicable To Common Shares	158.6M	(1.3B)	(950.1M)	(456.8M)	(411.1M)	(390.6M)
Tax Provision	35.3M	(39.9M)	(14.6M)	8.7M	27.4M	36.3M
Net Interest Income	(156.4M)	(235.1M)	(257.8M)	(295.2M)	(415.5M)	(394.7M)
Reconciled Depreciation	414.6M	363.7M	262.2M	184.6M	155.8M	250.9M

Additional Tools for Sabre Stock Analysis

When running Sabre Corpo's price analysis, check to measure Sabre Corpo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sabre Corpo is operating at the current time. Most of Sabre Corpo's value examination focuses on studying past and present price action to predict the probability of Sabre Corpo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sabre Corpo's price. Additionally, you may evaluate how the addition of Sabre Corpo to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sabre Historical Income Statement

About Sabre Income Statement Analysis

Sabre Corpo Income Statement Chart

Total Revenue

Cost Of Revenue

Total Operating Expenses

Sabre Corpo income statement Correlations

Sabre Corpo Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sabre Corpo income statement Accounts

Additional Tools for Sabre Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 0.98	Ebit
Net Income	+ 0.98	Income Before Tax
Income Before Tax	+ 0.97	Operating Income
Net Income From Continuing Ops	+ 0.97	Ebitda
Net Income	+ 0.96	Ebitda
Income Before Tax	+ 0.95	Ebit

Cost Of Revenue	- 0.88	Depreciation And Amortization
Extraordinary Items	- 0.85	Non Recurring
Extraordinary Items	- 0.85	Research Development
Reconciled Depreciation	- 0.82	Interest Expense
Extraordinary Items	- 0.8	Non Operating Income Net Other
Tax Provision	- 0.79	Research Development